5 things to watch on the ASX 200 on Friday

Mesoblast limited (ASX:MSB) and Woodside Petroleum Limited (ASX:WPL) shares will be on watch on the ASX 200 on Friday…

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Thursday the S&P/ASX 200 Index (ASX: XJO) returned to form and raced notably higher. The benchmark index climbed 1% to 5,872.9 points.

Will the market be able to build on this on Friday? Here are five things to watch:

ASX 200 expected to fall.

It looks set to be a disappointing end to the week for the ASX 200 despite a solid night of trade on Wall Street. According to the latest SPI futures, the ASX 200 is poised to open the day 26 points or 0.45% lower this morning. Overnight the Dow Jones rose 0.1%, the S&P 500 climbed 0.5%, and the Nasdaq stormed 1.4% higher.

Oil prices sink lower

Energy shares such as Beach Energy Ltd (ASX: BPT) and Woodside Petroleum Limited (ASX: WPL) could tumble lower on Friday after oil prices sank lower.  According to Bloomberg, the WTI crude oil price is down 3.9% to US$38.65 a barrel and the Brent crude oil price has dropped 3.5% to US$40.83 a barrel. A weak demand outlook and higher than expected OPEC production weighed on prices.

Gold price rises.

Gold miners such as Evolution Mining Ltd (ASX: EVN) Northern Star Resources Ltd (ASX: NST) could end the week on a positive note after the gold price pushed higher. According to CNBC, the spot gold price is up 0.8% to US$1,910.60 an ounce amid U.S. stimulus hopes.

Tech shares could storm higher.

It could be a good day for tech shares such as Afterpay Ltd (ASX: APT) and Appen Ltd (ASX: APX) after their U.S. peers stormed higher overnight. On Wall Street the tech-focused Nasdaq index recorded a strong 1.4% gain. The local sector has a tendency to follow the lead of the Nasdaq.

Mesoblast on watch.

It will be worth keeping an eye on the Mesoblast limited (ASX: MSB) share price on Friday. While the company isn't expecting to make an announcement on whether the US FDA has approved its remestemcel-L (RYONCIL) product for paediatric patients with steroid-refractory acute graft versus host disease until Monday, there's always a chance the FDA will move quicker than expected and give its verdict before the market open. The Mesoblast share price will remain halted until its release.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO and Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man holding Australian dollar notes, symbolising dividends.
Dividend Investing

Want to build up passive income? These 2 ASX dividend shares are a buy!

These stocks are giving investors exciting payouts every year.

Read more »

Man on a ladder drawing an increasing line on a chalk board symbolising a rising share price.
Growth Shares

2 ASX shares to buy and hold for the next decade

These businesses have a lot of growth potential ahead…

Read more »

Three satisfied miners with their arms crossed looking at the camera proudly
Materials Shares

ASX 200 materials sector outperforms as mining shares continue their ascent

Plenty of ASX 200 mining shares hit multi-year highs last week amid continually rising commodity values.

Read more »

A group of people push and shove through the doors of a store, trying to beat the crowd.
Broker Notes

2 ASX shares highly recommended to buy: Experts

Are these two stocks the best buys on the ASX?

Read more »

Smiling couple sitting on a couch with laptops fist pump each other.
Broker Notes

These ASX 200 shares could rise 20% to 55%

Brokers have good things to say about these shares.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Dividend Investing

I'd buy 5,883 shares of this ASX stock to aim for $1,000 of annual passive income

I’d pick this stock for its strong dividend record.

Read more »

A player pounces on the ball in the scoring zone of the field.
Best Shares

4 ASX 300 shares that ripped 100% or more in 2025

The S&P/ASX 300 Index rose 7.17% and delivered a total return, including dividends, of 10.66% in 2025.

Read more »